Right ventricular failure - Insights provided by a new model of chronic pulmonary hypertension

Transplantation

Volumn 63, Issue 2, 1997, Pages 209-216

  Chen, Edward P ^a,b   Bittner, Hartmuth B ^a   Davis, R Duane ^a   Van Trigt, Peter ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT; MILRINONE; MONOCROTALINE PYRROLE; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITOR; VASODILATOR AGENT;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; EXPERIMENTAL MODEL; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE CONTRACTILITY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0030894961     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199701270-00006     Document Type: Article

References (45)

1. Kreitt JM, Kaye MP. The Registry of the International Society for Heart Transplantation: seventh official report-1990. J Heart Transplant 1990; 9: 323.
2. Bourge RC, Kirklin JK, Naftel DC, White C, Mason DA, Epstein AE. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg 1991; 101: 432.
3. Griepp RB, Stinson EB, Dong E, Clark DA, Shumway NE. Determinants of operative risk in human heart transplantation. Am J Surg 1971; 122: 191.
4. Kirklin JK, Naftel DC, McGriffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1988; 11: 917.
5. Kirklin JK, Naftel DC, Kirklin JW, Blackstone EH, White-Williams C, Bourge RC. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant 1987; 7: 331.
6. Kormos RL, Thompson M, Hardesty RL, et al. Utility of preoperative right heart catheterization data a predictor of survival after heart transplantation. J Heart Transplant 1986; 5: 391.
7. 1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg 1992; 103: 33.
8. 1 and right ventricular assist. J Heart Transplant 1986; 5: 317.
9. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet 1991; 338: 1173.
10. Frostell C, Fractacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 1991; 83: 2038.
11. Tanaka H, Tajimi K, Matsumoto A, Kobayashi K. Vasodilatory effects of milrinone on pulmonary vasculature in dogs with pulmonary hypertension due to pulmonary embolism: a comparison with those of dopamine and dobutamine. Clin Exp Pharm Physiol 1990; 17: 681.
12. Girard C, Durand PG, Vedrinne C, et al. Inhaled nitric oxide for right ventricular failure after heart transplantation. J Cardiovasc Vasc Anesthesia 1993; 7: 481.
13. Chen EP, Bittner HB, Biswas SS, Campbell KA, Van Trigt P. An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation. J Heart and Lung Transplant 1996; 15: S55.
14. Mattocks AR, Jukes R, Brown J. Simple procedures for preparing putative toxic metabolites of pyrrolizidine alkaloids. Toxicon. 1989; 27: 561.
15. Glower DD, Spratt JA, Snow ND, et al. Linearity of the FrankStarling relationship in the intact heart: the concept of preload recruitable stroke work. Circulation. 1985; 71: 994.
16. Van Trigt P, Bittner HB, Kendall SW, Milano CA. Mechanisms of transplant right ventricular dysfunction. Ann Surg. 1995; 221: 666.
17. Armitage JM, Hardesty RL, Griffith BP. Prostaglandin E1: an effective treatment of right heart failure after orthotopic heart transplantation. J Heart Transplant 1987; 6: 348.
18. 1 treatment of pulmonary hypertension. Am Rev Respir Dis 1987; 136: 773.
19. 1, and sodium nitroprusside. J Heart Lung Transplant 1995; 14: 436.
20. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987; 84: 9265.
21. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524.
22. Roberts JD, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM. Inhaled nitric oxide in congenital heart disease. Circulation 1993; 87: 447.
23. Girard C, Lehot JJ, Pannetier JC, Filley S, French P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992; 77: 880.
24. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993; 328: 399.
25. Weitzberg E, Rudehill A, Lundberg JM. Nitric oxide inhalation attenuates pulmonary hypertension and improves as exchange in endotoxin shock. Eur J Pharmacol 1993; 233: 85.
26. Offner PJ, Ogura H, Jordan BS, Pruitt BA, Cioffi WG. Effects of nitric oxide on right ventricular function in endotoxin shock. J Trauma 1995; 39: 179.
27. Tanaka H, Tajimi K, Moritsune O, Kobayashi K, Okada K. Effects of milrinone on pulmonary vasculature in normal dogs and in dogs with pulmonary hypertension. Crit Care Med 1991; 19: 68.
28. Scott-Monrad E, Bairn DS, Smith H, et al. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 1985; 71: 972.
29. Skoyles JR, Sherry KM, Price C. Intravenous milrinone in patients with severe congestive cardiac failure awaiting heart transplantation. J Cardiothorac Vasc Anesth 1992; 6: 222.
30. Eichorn EJ, Konstam MA, Weiland DS, et al. Differential effects of milrinone and dobutamine on right ventricular preload, afterload, and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987; 60: 1329.
31. Sherry KM, Locke TJ. Use of milrinone in cardiac surgical patients. Cardiovasc Drug Ther 1993; 7: 671.
32. Williams TJ, Salamonsen RF, Snell G, Kaye D, Esmore DS. Preliminary experience with inhaled nitric oxide for acute pulmonary hypertension after heart transplantation. J Heart Lung Transplant 1995; 14: 419.
33. Van Bogaert A, Tosetti R. Experimental pulmonary hypertension. Br Heart J 1963; 25: 774.
34. McLean RF, Prielipp RC, Rosenthal MH, Pearl DG. Vasodilator therapy in microembolic porcine pulmonary hypertension. Anesth Analg 1990; 71: 35.
35. Hsieh CM, Mishkel GJ, Cardoso PFG, et al. Production and reversibility of right ventricular hypertrophy and right heart failure in dogs. Ann Thorac Surg 1992; 54: 104.
36. Attinger EO, Anne A, McDonald DA. Use of Fourier series for the analysis of biological systems. Biophys J 1966; 6: 291.
37. Milnor W, Bergel D, Bargaimer J. Hydraulic power associated with pulmonary blood flow and its relation to heart rate. Circ Res 1966; 19: 467.
38. Meyers CH, Purut CM, D'Amico TA, et al. Pulmonary artery impedance after single lung transplantation. J Surg Res 1992; 52: 459.
39. Krayenbuehl HP, Turina J, Hess O. Left ventricular function in chronic pulmonary hypertension. Am J Cardiol 1978; 41: 1150.
40. Louie EK, Rich S, Brundage BH. Doppler echocardiographic assessment of impaired left ventricular filling in patients with right ventricular pressure overload due to primary pulmonary hypertension. J Am Coll Cardiol 1986; 8: 1298.
41. Handa S, Miyamori R, Ohnishi S, et al. Left ventricular geometry and contraction in patients with primary pulmonary hypertension. Circ 1985; 72(suppl III): III-411.
42. Badke FR. Left ventricular dimensions and function during right ventricular pressure overload. Am J Physiol 1982; 242: H611.
43. Bove AA, Santamore WP. Ventricular interdependence. Prog Cardiovasc Dis 1981; 23: 365.
44. Khaja F, Parker JO. Right and left ventricular performance in chronic obstructive lung disease. Am Heart J 1971; 82: 319.
45. Goodman DJ, Harrison DC, Popp RL. Echocardiographic features of primary pulmonary hypertension. Am J Cardiol 1974; 33: 438.